BR9908605A - Kit anticoncepcional, uso de um composto esteróide, e, processo de contracepção - Google Patents

Kit anticoncepcional, uso de um composto esteróide, e, processo de contracepção

Info

Publication number
BR9908605A
BR9908605A BR9908605-0A BR9908605A BR9908605A BR 9908605 A BR9908605 A BR 9908605A BR 9908605 A BR9908605 A BR 9908605A BR 9908605 A BR9908605 A BR 9908605A
Authority
BR
Brazil
Prior art keywords
steroids
steroid compound
contraception
kit
contraceptive
Prior art date
Application number
BR9908605-0A
Other languages
English (en)
Inventor
Helenius Jan Kloosterboer
Godefridus Hermanus Jo Deckers
Johannes Antonius Mar Hamersma
Pieter Michiel Verbost
Herman Jan Tijmen Coel Bennink
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR9908605A publication Critical patent/BR9908605A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

"KIT ANTICONCEPCIONAL, USO DE UM COMPOSTO ESTERóIDE, E, PROCESSO DE CONTRACEPçãO". A invenção diz respeito a um kit anticoncepcional compreendendo um meio para a administração diária de um agente anticoncepcional caracterizado pelo fato de que esse agente anticoncepcional único é um composto esteróide que possui um perfil inerente de atividade que combina atividades progestagênica e estrogênica. Dentro de uma classe geral de compostos esteróides conhecidos, foram descobertos esteróides que possuem um preponderante perfil combinado de propriedades biológicas para uso em anticoncepção, especialmente por meio de monoterapia. Esses esteróides são selecionados do grupo que consiste de esteróides que satisfazem a fórmula estrutural (I), Error! No topic specified. e as prodrogas do mesmo, onde as linhas pontilhadas indicam, cada uma e de forma independente, uma ligação opcional.
BR9908605-0A 1998-03-09 1999-03-03 Kit anticoncepcional, uso de um composto esteróide, e, processo de contracepção BR9908605A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98200744 1998-03-09
PCT/EP1999/001404 WO1999045886A2 (en) 1998-03-09 1999-03-03 New contraceptive kit for monotherapy

Publications (1)

Publication Number Publication Date
BR9908605A true BR9908605A (pt) 2001-04-24

Family

ID=8233452

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908605-0A BR9908605A (pt) 1998-03-09 1999-03-03 Kit anticoncepcional, uso de um composto esteróide, e, processo de contracepção

Country Status (20)

Country Link
EP (1) EP1061928A2 (pt)
JP (1) JP2002506014A (pt)
KR (1) KR20010041698A (pt)
CN (1) CN1292702A (pt)
AR (1) AR018313A1 (pt)
AU (1) AU756882B2 (pt)
BR (1) BR9908605A (pt)
CA (1) CA2319765A1 (pt)
CO (1) CO5070598A1 (pt)
HU (1) HUP0101007A3 (pt)
ID (1) ID25621A (pt)
IL (1) IL137541A0 (pt)
NO (1) NO20004492D0 (pt)
NZ (1) NZ506115A (pt)
PE (1) PE20000330A1 (pt)
PL (1) PL343428A1 (pt)
RU (1) RU2225714C2 (pt)
TR (1) TR200002593T2 (pt)
WO (1) WO1999045886A2 (pt)
ZA (1) ZA991851B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4134599A (en) * 1998-04-07 1999-10-25 Akzo Nobel N.V. Progestogen-only contraceptive kit
ATE295851T1 (de) 1999-09-06 2005-06-15 Akzo Nobel Nv Nicht-aromatische estrogenische steroide mit einem 11-hydrocarbyl substituent
ATE294812T1 (de) 2000-07-28 2005-05-15 Akzo Nobel Nv 16alpha-methyl oder ethyl substituierte oestrogene
CA2478165A1 (en) * 2002-03-11 2003-09-25 Janssen Pharmaceutica N.V. Sulfatase inhibiting progestogen-only contraceptive regimens
WO2003077925A1 (en) * 2002-03-11 2003-09-25 Janssen Pharmaceutica N.V. Sulfatase inhibiting continuous progestogen contraceptive regimens
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints

Also Published As

Publication number Publication date
TR200002593T2 (tr) 2000-12-21
PE20000330A1 (es) 2000-05-16
AU756882B2 (en) 2003-01-23
HUP0101007A2 (hu) 2001-12-28
NO20004492L (no) 2000-09-08
AR018313A1 (es) 2001-11-14
CA2319765A1 (en) 1999-09-16
ID25621A (id) 2000-10-19
NZ506115A (en) 2003-07-25
HUP0101007A3 (en) 2002-02-28
JP2002506014A (ja) 2002-02-26
PL343428A1 (en) 2001-08-13
ZA991851B (en) 1999-09-22
CN1292702A (zh) 2001-04-25
WO1999045886A3 (en) 1999-12-02
AU3143799A (en) 1999-09-27
IL137541A0 (en) 2001-07-24
EP1061928A2 (en) 2000-12-27
NO20004492D0 (no) 2000-09-08
RU2225714C2 (ru) 2004-03-20
CO5070598A1 (es) 2001-08-28
WO1999045886A2 (en) 1999-09-16
KR20010041698A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
AR011480A1 (es) ACIL-ANILIDAS SUSTITUIDAS CON RADICALES (HETERO) CICLICOS, NO ESTEROIDALES, CON ACTIVIDAD GESTÁGENA Y ANDRoGENA MIXTA.
ES2174920T3 (es) Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno.
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
PT915898E (pt) Forma i cristalina de claritromicina
NO20012977L (no) N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
TR200002774T2 (tr) Alzheimer hastalığının tedavisi için steroit sapogenler ve bunların türevleri
BR9813989A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo para o tratamento de um paciente sofrendo de uma condição
BR9907788A (pt) Agentes antiinflamatórios seletivos paraglicocorticóides
BR0012489A (pt) Composto, composição farmacêutica, uso de um composto, e, kit para a contracepção masculina
BR9907847A (pt) Agentes anti-inflamatórios seletivos para glucocorticóides
NO20002676L (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
BR0211739A (pt) Novas formas polimórficas cristalinas de cloridrato de lercanidipina e processo para preparação das mesmas
WO1995018821A3 (en) Novel antiandrogenic agents and related pharmaceutical compositions and methods of use
BR9908605A (pt) Kit anticoncepcional, uso de um composto esteróide, e, processo de contracepção
AU580963B2 (en) New compounds derived from diphenyl-methylene-ethylamine
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
BR0013769A (pt) Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide
DE60201415D1 (de) Bisarylderivate mit fsh rezeptor modulierender aktivität
ID27440A (id) Proses untuk menyiapkan penengah-penengah
WO2000058328A3 (de) Avermectinderivate
BG106078A (en) Thio-oxindole derivatives
GB1530837A (en) 3beta-(1-alkoxyethoxy)-steroids and their use in the production of steroids from sarsaponin
NO20020260D0 (no) 11<beta>-aryl-17,17-spirotiolansubstituerte steroider
UY26435A1 (es) Compuestos bis-básicos como inhibidores de triptasa, procedimiento para su preparación y su utilización como medicamentos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTA A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.